| 1. |
- Clarke, Robert, et al.
(författare)
-
Lowering blood homocysteine with folic acid based supplements : Meta-analysis of randomised trials
- 1998
-
Ingår i: British Medical Journal. - : BMJ. - 0959-8146. ; 316:7135, s. 894-898
-
Forskningsöversikt (refereegranskat)abstract
- Objective: To determine the size of reduction in homocysteine concentrations produced by dietary supplementation with folic acid and with vitamins B-12 or B-6. Design: Meta-analysis of randomised controlled trials that assessed the effects of folic acid based supplements on blood homocysteine concentration. Multivariate regression analysis was used to determine the effects on homocysteine concentrations of different doses of folic acid and of the addition of vitamin B-12 or B-6. Subjects: Individual data on 1114 people included in 12 trials. Findings: The proportional and absolute reductions in blood homocysteine produced by folic acid supplements were greater at higher pretreatment blood homocysteine concentrations (P < 0.001) and at lower pretreatment blood folate concentrations (P < 0.001). After standardisation to pretreatment blood concentrations of homocysteine of 12 μmol/l and of folate of 12 nmol/l (approximate average concentrations for Western populations), dietary folic acid reduced blood homocysteine concentrations by 25% (95% confidence interval 23% to 28%; P < 0.001), with similar effects in the range of 0.5-5 mg folic acid daily. Vitamin B-12 (mean 0.5 mg daily) produced an additional 7% (3% to 10%) reduction in blood homocysteine. Vitamin B-6 (mean 16.5 mg daily) did not have a significant additional effect. Conclusions: Typically in Western populations, daily supplementation with both 0.5-5 mg folic acid and about 0.5 mg vitamin B-12 would be expected to reduce blood homocysteine concentrations by about a quarter to a third (for example, from about 12 μmol/l to 8-9 μmol/l). Large scale randomised trials of such regimens in high risk populations are now needed to determine whether lowering blood homocysteine concentrations reduces the risk of vascular disease.
|
|
| 2. |
- Allen, Marie, et al.
(författare)
-
Mitochondrial DNA sequencing of shed hairs and saliva on robbery caps : sensitivity and matching probabilities
- 1998
-
Ingår i: Journal of Forensic Sciences. - 0022-1198 .- 1556-4029. ; 43:3, s. 453-464
-
Tidskriftsartikel (refereegranskat)abstract
- Sequencing of mitochondrial DNA (mtDNA) has been used for human identification based on teeth and skeletal remains. Here, we describe an amplification system for the mtDNA control region (D-loop) suited for the analysis of shed hair, which constitutes the most common biological evidence material in forensic investigations. The success rate was over 90% when applied to evidence materials such as shed hair, saliva stains and saliva on stamps. The analysis of evidence materials collected from three similar robberies revealed the presence of mtDNA sequences identical to those of the suspects in the three crimes. The use of mtDNA control region sequences for individual identification was evaluated. The probability of identity by chance for the mtDNA types of the suspects in the robberies was found to vary between Pr = 0.017 - < 0.0017, depending on the reference population used, emphasizing the need for large population databases to obtain the appropriate estimate.
|
|
| 3. |
- Allen, Rodney, et al.
(författare)
-
Setting of Zn-Cu-Au-Ag massive sulfide deposits in the evolution and facies architecture of a 1.9 Ga marine volcanic arc : Skellefte district, Sweden
- 1996
-
Ingår i: Economic geology and the bulletin of the Society of Economic Geologists. - : Society of Economic Geologists. - 0361-0128 .- 1554-0774. ; 91:6, s. 1022-1053
-
Tidskriftsartikel (refereegranskat)abstract
- Skellefte mining district occurs in an Early Proterozoic, mainly 1.90-1.87 Ga (Svecofennian) magmatic province of low to medium metamorphic grade in the Baltic Shield in northern Sweden. The district contains over 85 pyritic Zn-Cu-Au-Ag massive sulfide deposits and a few vein Au deposits and subeconomic porphyry Cu-Au-Mo deposits, The massive sulfide deposits mainly occur within, and especially along the top of: a regional felsic-dominant volcanic unit attributed to a stage of intense, extensional, continental margin are volcanism. From facies analysis we interpret the paleogeography of this stage to have comprised many scattered islands and shallow-water areas. surrounded by deeper seas. All the major massive sulfide ores occur in below-wave base facies associations: however, some ores occur close to stratigraphic intervals of above-wave base facies associations, and the summits of some volcanoes that host massive sulfides emerged above sea level. Intense marine volcanism was superceded at different times in different parts of tile district by a stage of reduced volcanism, uplift resulting in subregional disconformities, and then differential uplift and subsidence resulting in a complex horst and graben paleogeography. Uplift of the are is attributed to the relaxation of crustal extension and the emplacement of granitoids to shallow crustal levels. A few massive sulfide ores formed within the basal strata of this second stage. The horst and graben system was filled by prograding fluvial-deltaic sediments and mainly mafic lavas, and during this stage the Skellefte district was a transitional area between renewed are volcanism of more continental character to the north, and subsidence and basinal mudstone-turbidite sedimentation to the south. This whole volcanotectonic cycle occurred within 10 to 15 m.y. We define 26 main volcanic, sedimentary, and intrusive facies in the Skellefte district. The most abundant facies are (1) normal-graded pumiceous breccias, which are interpreted as syneruptive subaqueous mass flow units of pyroclastic debris, (2) porphyritic intrusions, and (3) mudstone and sandstone turbidites. Facies associations define seven main volcano types, which range from basaltic shields to andesite cones and rhyolite calderas. Despite this diversity of volcano types, most massive sulfide ol es are associated with one volcano type: subaqueous rhyolite cryptodome-tuff volcanoes. These rhyolite volcanoes are 2 to 10 km in diameter, 250 to 1,200 m thick at the center, and are characterized by a small to moderate volume rhyolitic pyroclastic unit, intruded by rhyolite cryptodomes, sills, and dikes. Massive sulfide ores occur near the top of the proximal (near vent) facies association The remarkable coincidence in space and time between the ores and this volcano type indicates an intimate, genetic relationship between the ores and the magmatic evolution of the volcanoes.Many of the massive sulfide ores occur within rapidly emplaced volcaniclastic facies and are interpreted to have formed by infiltration and replacement of these facies. Some of the ore deposits have characteristics of both marine massive sulfides and subaerial epithelial deposits. We suggest that massive sulfides in the Skellefte district span a range in ore deposit style from deep-water sea floor ores, to subsea-floor replacements, to shallow-water and possible subaerial synvolcanic replacements. Facies models are provided for the mineralized rhyolite volcanoes and volcanological guides are provided for exploration for blind ores within these volcanoes.
|
|
| 4. |
|
|
| 5. |
|
|
| 6. |
- Pugliese, Alberto, et al.
(författare)
-
Sequence analysis of the diabetes-protective human leukocyte antigen-DQB1*0602 allele in unaffected, islet cell antibody-positive first degree relatives and in rare patients with type 1 diabetes
- 1999
-
Ingår i: Journal of Clinical Endocrinology and Metabolism. - : The Endocrine Society. - 0021-972X .- 1945-7197. ; 84:5, s. 1722-1728
-
Tidskriftsartikel (refereegranskat)abstract
- The human leukocyte antigen (HLA)-DQA1*0102/DQB1*0602/DRB1*1501 (DR2) haplotype confers strong protection from type 1 diabetes. Growing evidence suggests that such protection may be mostly encoded by the DQB1*0602 allele, and we reported that even first degree relatives with islet cell antibodies (ICA) have an extremely low diabetes risk if they carry DQB1*0602. Recently, novel variants of the DQB1*0602 and *0603 alleles were reported in four patients with type 1 diabetes originally typed as DQB1*0602 with conventional techniques. One inference from this observation is that DQB1*0602 may confer absolute protection and may never occur in type 1 diabetes. By this hypothesis, all patients typed as DQB1*0602 positive with conventional techniques should carry one of the above diabetes-permissive variants instead of the protective DQB1*0602. Such variants could also occur in ICA/DQB1*0602-positive relatives, with the implication that their diabetes risk could be significantly higher than previously estimated. We therefore sequenced the DQB1*0602 and DQA1*0102 alleles in all ICA/DQB1*0602-positive relatives (n = 8) previously described and in six rare patients with type 1 diabetes and DQB1*0602. We found that all relatives and patients carry the known DQB1*0602 and DQA1*0102 sequences, and none of them has the mtDNA A3243G mutation associated with late-onset diabetes in ICA-positive individuals. These findings suggest that diabetes-permissive DQB1*0602/3 variants may be very rare. Thus, although the protective effect associated with DQB1*0602 is extremely powerful, it is not absolute. Nonetheless, the development of diabetes in individuals with DQB1*0602 remains extremely unlikely, even in the presence of ICA, as confirmed by our further evaluation of ICA/DQB1*0602-positive relatives, none of whom has yet developed diabetes.
|
|
